Evidence map›Paper›PMID 41012465›Full record

ArticlePharmaceutics2025

Randomized Clinical Trial for the Optimization of Dyslipidemia Management in Patients with End-Stage Renal Disease Undergoing In-Hospital Maintenance Hemodialysis Therapy.

Sadia Rehman, Muhammad Farhan, Muhammad Raza Sarfraz, Asma Naveed, Fahad Usman, Anila Bibi, Raheel Ahmed, Hiya Huq, Ali Hasan, Jarin Anzoom and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sadia RehmanDepartment of Biochemistry, Bahria University of Health Sciences Campus Karachi, Karachi 74400, Pakistan.
Muhammad FarhanDepartment of Biochemistry, University of Karachi, Karachi 75270, Pakistan.
Muhammad Raza SarfrazAllied Hospital, Faisalabad Medical University, Faisalabad 38000, Pakistan.ORCID 0000-0002-2735-9852
Asma NaveedDepartment of Nephrology, PNS Shifa Hospital, Karachi 75530, Pakistan.
Fahad UsmanDepartment of Community Medicine and Public Health, Sialkot Medical College, Sialkot 51310, Pakistan.ORCID 0009-0001-6692-3129
Anila BibiDepartment of Biochemistry, Jinnah Sindh Medical University, Karachi 75510, Pakistan.
Raheel AhmedDepartment of Medicine, National Heart and Lung Institute, Imperial College London, London SW7 2AZ, UK.
Hiya HuqDepartment of Psychology, Health and Professional Development, Oxford Brookes University, Oxford OX3 0BP, UK.
Ali HasanDepartment of Medicine, National Heart and Lung Institute, Imperial College London, London SW7 2AZ, UK.ORCID 0009-0009-8612-1375
Jarin AnzoomSchool of Allied and Public Health, University of Chester, Chester CH1 4BJ, UK.
Pobitro KumarDepartment of Medicine, Rangpur Medical College, Rangpur 5400, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acetylcarnitinecarnitinehemodialysishyperlipidemiasrenal replacement therapy

Identifiers

PMID41012465
PMCPMC12473649

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.